Somewhere outside Kandahar around 2010, a technician in a shipping container packed with lab gear holds a twisted piece of sheet metal that an hour earlier was part of a roadside bomb. She dusts it, lifts a latent fingerprint, swabs the surface for touch DNA, and runs both against a database. If there is a match, a name that was invisible the day before is suddenly attached to that device, and to every other device built by the same pair of hands. That container is one node of something the Pentagon calls the DoD Forensic Enterprise, a coordinated web of military crime labs and battlefield forensic teams that the Department of Defense estimates cost it somewhere between $800 million and $1 billion to operate overseas from 2005 through 2012. The Army runs it, most Americans have never heard of it, and it is one of the few big war-era investments that came home and kept working.
What the enterprise actually is
The DoD Forensic Enterprise, or DFE, is not a single building or a single program office. It is the umbrella term for the full range of forensic capabilities the military maintains across its services. That includes the disciplines most people picture when they hear the word forensics, DNA and serology, latent fingerprints, firearms and toolmarks, questioned documents, drug chemistry, and trace materials, plus the branch of the field the civilian world rarely sees, forensic medicine. Forensic medicine covers pathology, anthropology, toxicology, and the DNA identification of human remains. In a military context that last mission is not abstract. It is how the Department puts names to the recovered remains of service members, sometimes decades after they were lost.
The permanent institutional core of all of this sits in Forest Park, Georgia, at the Defense Forensic Science Center, formerly the U.S. Army Criminal Investigation Laboratory. By the Army's own description it is the Department of Defense's only full service forensic laboratory, offering criminal investigators from every branch a suite of forensic services, from DNA to latent print and trace analysis, and it serves as the program manager for the DoD Convicted Offender DNA Databasing Program. That is the enduring layer. The layer that made the enterprise famous, and expensive, was the wartime one. During the Iraq and Afghanistan campaigns the same enterprise pushed deployable expeditionary labs into theater, close enough to the fight that evidence pulled off a bomb fragment in the morning could shape an operation by nightfall. This is the part of the story that belongs to the wider question of what the United States built during two long wars and what happened to it afterward.
The Army holds the badge
The military organizes shared missions like this one through a mechanism called an Executive Agent. Rather than let every service build its own overlapping version of a capability, the Department designates one component to run a function on behalf of all of them. For forensics, that component is the Army. According to the DoD Executive Agent registry maintained by the Office of the Secretary of Defense, the Secretary of the Army is the designated DoD Executive Agent for the DoD Forensic Enterprise, and the designating issuance is DoD Directive 5205.15E, dated April 26, 2011.
That directive did more than hand the Army a title. It formally established the DoD Forensic Enterprise, stood up a Forensic Executive Committee to coordinate policy across the services, and spelled out the specific disciplines the enterprise is responsible for, the DNA and serology, firearms and toolmarks, latent prints, questioned documents, drug chemistry, and trace materials on the criminal side, and the pathology, anthropology, toxicology, and human remains DNA identification on the forensic medicine side. In plain terms, the 2011 directive took a set of capabilities that had grown up in wartime under enormous pressure and tried to turn them into a governed, permanent institution with an owner. Whether the governance kept pace with the mission is exactly where the honest critique begins.
The money, and why the band is so wide
There is one primary figure that anchors the cost of this enterprise, and it deserves to be stated with care. In its 2013 report GAO-13-447, the Government Accountability Office reported that the Department of Defense estimated it spent between $800 million and $1 billion in Overseas Contingency Operations funds to support expeditionary forensics activities in Iraq and Afghanistan from 2005 through 2012. Read that sentence slowly, because each qualifier matters.
First, this is money spent, not money projected. It is a retrospective look at funds already outlaid across an eight-year span, not a future budget request or a program-of-record forecast. Second, it is not a contract ceiling. It is not the maximum value of some vendor agreement that may or may not have been fully drawn down. It is a Department-wide expenditure estimate spread across multiple components and years. Third, and most important, it is an estimate with a deliberately wide band, and the width of that band is itself a finding. The gap between the low end and the high end is $200 million. That is not rounding. GAO reported that DoD officials experienced real challenges identifying the costs associated with expeditionary forensic capabilities, and that the Office of the Under Secretary of Defense for Acquisition, Technology, and Logistics had not reviewed and evaluated the adequacy of the components' forensic budget estimates as the governing directive required. In other words, the Department could not tell GAO with precision what its own battlefield forensics had cost. The $800 million to $1 billion range is the honest expression of that uncertainty. Anyone who repeats this figure should carry the caveat with it. It is DoD's own estimate, framed as a band because the visibility was not there to make it a point.
Where the oversight thinned out
The efficiency critique of the DoD Forensic Enterprise is not a story of a broken system or a scandal of stolen money. It is a quieter and in some ways more familiar story about planning that drifted and oversight that did not keep up with the mission. GAO-13-447 found that the Department's forensic strategic plan had sat in draft form for roughly two years and, even in draft, lacked the elements that make a strategic plan useful, the approaches, milestones, metrics, and resource requirements that would let leaders know whether the enterprise was on track and what it needed. Combine a plan stuck in draft with the budget-review gap described above, and you get the core problem GAO identified, a Department that had built a genuinely valuable capability under fire but could not clearly say what it cost, how it was resourced, or how its pieces were supposed to fit together going forward.
Four years later, GAO returned to the neighboring subject in GAO-17-580, its 2017 review of DoD biometrics and forensics. The findings there rhymed with the earlier ones. GAO reported that the Army had bypassed DoD acquisition protocols on a key biometric capability and, in doing so, may have missed cheaper existing alternatives that could have met the need. It found that no single entity owned a biometric strategic plan, another version of the ownership and planning gap. And it flagged a concrete operational risk, that the authoritative database underpinning these capabilities lacked a geographically dispersed backup, meaning a single point of failure sat under a system the military had come to rely on. The through line across both reports is consistent, weak cost visibility, planning drift, and acquisition shortcuts. That is a serious critique. It is also, notably, not an allegation of fraud or of a capability that failed to deliver. The complaint is about how the enterprise was governed, not about whether it worked.
What it buys that nothing else does
The public-good case for the DoD Forensic Enterprise is strong, and it is strongest precisely because the capability is dual use, valuable in a courtroom and valuable on a battlefield. The Defense Forensic Science Center is, by the Army's account, the only full service accredited forensic laboratory in the entire Department, and it does not serve the Army alone. Criminal investigators from every military branch send evidence there for DNA, latent print, firearms, trace, and questioned document analysis, and the center runs the DoD convicted offender DNA database. Strip the wartime story away entirely and you are still left with a single accredited lab doing the forensic work behind military criminal justice across all the services, which is a real and enduring function.
Then there is the forensic medicine mission, which is easy to overlook and hard to overstate. The identification of human remains, including the remains of fallen service members, is forensic work of a particular moral weight. It is the discipline that lets the country return a name and a certainty to a family. And in the wars themselves, the expeditionary layer of the enterprise did something that had rarely been possible before. By pulling fingerprints and DNA off the components of improvised explosive devices, forensic teams tied specific bombs to specific bomb makers, feeding both immediate battlefield targeting and, later, criminal prosecutions of the people responsible. GAO-17-580 put a number on the combined output. It reported that since 2008 DoD used its combined biometric and forensic capabilities to capture or kill about 1,700 individuals and to deny about 92,000 individuals access to military bases. Those figures deserve their own precision, because GAO attributes them to biometric and forensic capabilities working together, not to forensics alone. They are a measure of the joint system, not of the crime labs in isolation. Even read carefully, though, they describe a capability that did tangible work, and GAO credited the Department with genuine progress in standing up long-term deployable forensic capabilities that outlived the wars that created them.
Reading the ledger
Set the two verdicts side by side and neither cancels the other. On one side of the ledger sits a Department that spent somewhere between $800 million and $1 billion of war funding on a capability it could not fully account for, that let its strategic plan languish in draft for two years, that skipped acquisition steps and possibly cheaper alternatives, and that left a critical database without a geographic backup. On the other side sits a single accredited laboratory that serves every branch of the armed forces, a forensic medicine mission that puts names to the fallen, and a wartime forensic capability that tied bombs to the people who built them and, unlike so many contingency investments, survived the drawdown and came home to do civilian criminal justice work. The uncomfortable truth the ledger holds is that both of those things are simultaneously true. The DoD Forensic Enterprise is a real success in what it does and a real example of the government's chronic difficulty saying what its own successes cost. The right conclusion is not to pick one line of the ledger and print it as the headline. It is to insist that a capability this valuable is exactly the kind that deserves the cost visibility and the finished strategic plan it went most of two decades without.
Related reading
- The Afghan networks we built and left behind: another wartime capability whose real cost and afterlife are hard to trace.
- The biometric exit system that never shipped: the civilian mirror image, biometric identity as a program that struggled to deliver.
- DCGS-Army versus Palantir: the same Army acquisition instincts and the same fights over cost, ownership, and off-the-shelf alternatives.
- The index of programs, lifelines, and boondoggles: the full catalog this entry belongs to.
- The working ledgers: how these cost figures are traced back to primary sources.
Fact-check notes and sources
- The Secretary of the Army is the designated DoD Executive Agent for the DoD Forensic Enterprise, and the designating issuance is DoD Directive 5205.15E, dated April 26, 2011, which established the enterprise and the Forensic Executive Committee and named the covered disciplines. Verified against the DoD Executive Agent registry and the text of DoD Directive 5205.15E. Note: the official copy of the directive is hosted behind bot protection that blocks automated fetchers, but its existence and its Executive Agent designation are independently confirmed in the GAO source below.
- The load-bearing figure, that DoD estimated it spent between $800 million and $1 billion in Overseas Contingency Operations funds on expeditionary forensics in Iraq and Afghanistan from 2005 through 2012, is DoD's own estimate as reported in GAO-13-447 (2013). It is money spent, not projected, and not a contract ceiling. The $200 million band is deliberately wide because GAO found DoD lacked visibility into actual costs and that OUSD(AT&L) had not reviewed component forensic budget estimates as required. Treat it as an approximate departmentwide expenditure estimate, not a precisely tracked figure.
- The planning and oversight critique, a forensic strategic plan stuck in draft for about two years without required approaches, milestones, metrics, and resource requirements, comes from GAO-13-447 (2013). The related findings, that the Army bypassed DoD acquisition protocols on a key biometric capability and may have missed cheaper alternatives, that no entity owned a biometric strategic plan, and that the authoritative database lacked a geographically dispersed backup, come from GAO-17-580 (2017).
- The operational output figures, that since 2008 DoD used its combined biometric and forensic capabilities to capture or kill about 1,700 individuals and to deny about 92,000 individuals access to military bases, are from GAO-17-580 (2017). GAO attributes these to combined biometric and forensic capabilities, so they should not be read as forensics-only outcomes.
- The description of the Defense Forensic Science Center (formerly USACIL) as the Department of Defense's only full service forensic laboratory, offering criminal investigators from every branch a full suite of forensic services and serving as program manager for the DoD Convicted Offender DNA Databasing Program, is an Army and DFSC self-description, per the Army Criminal Investigation Division capabilities page, not an independent GAO finding, and carries its per-the-Army attribution accordingly.
This post is informational and journalistic, drawn from public records including GAO reports and DoD issuances, and is not legal, financial, or policy advice; all dollar figures are attributed to their fiscal year and to the reports in which they appear.